News & insights

Service | 23.06.2025

Controlling Cryptosporidiosis With Paromomycin Sulphate In Neonatal Dairy Calves

Article | 01.05.2025

Viability Of Cryptosporidium Spp. Oocysts Subjected To Two Commercial Disinfectants

Article | 28.04.2025

Cryptosporidium Parvum In Dairy Calves: Global Prevalence, Economic Impact And Return On Investment With An Effective Treatment

Article | 17.04.2025

Evaluating The Environmental Footprint Of Two European Coccidiosis Control Programmes

Article | 16.04.2025

Reducing The Carbon Footprint Of Broiler Production Using The Maximum Matrix Values Of Huvepharma Enzymes

global presence

Local support from a global company

Huvepharma® has a distribution network which covers more than 90 countries in 6 continents. Find your nearest Huvepharma® representative today.

Find your local contact

about us

Huvepharma®

Huvepharma® is a fast-growing, global pharmaceutical company with a focus on developing, manufacturing and marketing human and animal health and nutrition products.

more about us

Subscribe to our monthly updates and other company news by completing the form below

Full name*

Email*

Company*

I acknowledge that I have read the Privacy Statement.

I allow Huvepharma and its affiliates to send me email communications. You can manage your subscriptions and unsubscribe at any time here.

Change country

The Huvepharma® distribution network covers 90 countries in 6 continents. Please select a country from the list below to see the products and services available in that region.

To view all products and services, select Global from the dropdown menu or click here.

Change language

Huvepharma has a remarkable distribution network which covers 90 countries in 6 continents. To offer you the best services, we ask you to select your country.

Europe

United States

Click here to visit the local website or close this popup to stay on the global website.

top

Your browser is out of date!

Update your browser to view this website correctly. Update my browser now

News & insights

Huvepharma Publishes UK 2024 Coccidiosis Report

Bacterial Lameness And The (Non)Sense Of Probiotics

What Environmental Benefits Do Our Products Bring To Pig Producers?

How To Reduce The Carbon Footprint Of Pig Production

The Environmental Impact Of Pig Production

Monimax Cuts Losses Due To Coccidiosis

Controlling Cryptosporidiosis With Paromomycin Sulphate In Neonatal Dairy Calves

Viability Of Cryptosporidium Spp. Oocysts Subjected To Two Commercial Disinfectants

Cryptosporidium Parvum In Dairy Calves: Global Prevalence, Economic Impact And Return On Investment With An Effective Treatment

Evaluating The Environmental Footprint Of Two European Coccidiosis Control Programmes

Reducing The Carbon Footprint Of Broiler Production Using The Maximum Matrix Values Of Huvepharma Enzymes

global presence

Local support from a global company

about us

Huvepharma®

Change country

Africa

Asia

Europe

North America

Oceania

South America

Change language

Europe

United States

Your browser is out of date!